Cannabinoid Investment Portfolios

Avicanna Inc. Announces Auditor Transition Aug 3, 2024

Enveric Biosciences Reveals Decline in Revenue for Q3 2023 Amid Advancements of Psychedelics into Clinical Trials Nov 15, 2023

SciSparc's SCI-110 Shows Promise in Phase IIb Trial for Tourette Syndrome Nov 13, 2023